Fischer Pharmaceutical Ltd., a multi-national company specializing in R&D and manufacture of a wide variety of skin and health care products, has retained TransMedia Group to introduce Israel’s most popular sunscreen, Dr. Fischer ULTRASOL, in the Unite…
Category: News
Coaxial MICS With Toric IOL Improves Visual Acuity, Reduces Astigmatism
Coaxial microincision cataract surgery with toric IOL implantation was safe, effective and predictable in eyes with high corneal astigmatism, a study found.
With Diabetes, Untreated Depression Can Lead To Serious Eye Disease
Patients with diabetes who also suffer from depression are more likely to develop a serious complication known as diabetic retinopathy, a disease that damages the eye’s retina, a five-year study finds…
Eyes With Type 1 ROP Show Benefit Of Early Treatment At 6 Years
Early treatment of type 1 retinopathy of prematurity may improve grating visual acuity outcomes, a study found.
ISTA Pharmaceuticals Reports Results From The First Of Two Trials In The REMURA(TM) Phase 3 Clinical Program For Dry Eye Disease
ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA), today announced top-line results from the first of its two Phase 3 studies to evaluate the short-term safety and efficacy of two concentrations of REMURA(TM) (bromfenac ophthalmic solution for dry eye) in alle…
Free Cataract Screenings
Approximately 20.5 million Americans age 40 and older have cataracts and half of people 80 and older will develop cataracts.
Burned Out? How Doctors Recover Their Spark
Many doctors feel demoralized, have lost their hope and ideals, and have emotionally disengaged from the practice of medicine. Here’s how they reinvigorate themselves. Medscape Business of Medicine
Ophthalmologist Helps Develop Device For Monitoring Degenerative Eye Disease
An ophthalmologist at UT Southwestern Medical Center has helped create a convenient device that lets patients who have a degenerative eye disease better track vision changes. With the hand-held digital device, called myVisionTrack, patients can now per…
Presentation Predicts Prognosis in OMS
Severe presentation of opsoclonus-myoclonus syndrome (OMS) and early age at onset predict long-term neurocognitive sequelae, UK researchers say. Reuters Health Information
AcuFocus KAMRAT Inlay, Revolutionary Presbyopia Correction Technology, Exceeds 5,000 Implants Globally
Irvine, CA – July 26, 2011 – AcuFocus (www.AcuFocus.com), maker of an innovative corneal inlay that may revolutionize the treatment of near vision loss (presbyopia), today announced significant procedural growth since 2010 with the global launch of the…
Struggling With Meaningful Use Requirements? These Experts Help for Free
EHR meaningful use requirements can be confusing and difficult to implement. It’s possible to get expert help without paying for it. Here’s how. Medscape Business of Medicine
Struggling With Meaningful Use Requirements? These Experts Help With No Hassle
EHR meaningful use requirements can be confusing and difficult to implement. It’s possible to get expert help without paying for it. Here’s how. Medscape Business of Medicine
New convenient device for tracking degenerative eye disease
An ophthalmologist at UT Southwestern Medical Center has helped create a convenient device that lets patients who have a degenerative eye disease better track vision changes.
Webinar: Why You Need a Slit Lamp Camera
Featured Article
Ranibizumab And Bevacizumab Show Equivalent Effects On Visual Acuity In Patients With Neovascular AMD
Two of the most commonly used treatments for neovascular age-related macular degeneration (AMD), ranibizumab (Lucentis, Genentech), approved in 2006 by FDA, and the other commonly used ‘off-label,’ bevacizumab (Avastin, Genentech), resulted in similar …
iPhone-Based Device Monitors Macular Degeneration
A new iPhone app could enable patients with degenerative eye diseases to track their vision loss at home. Known as myVisionTrack, the technology allows patients with diabetic retinopathy or macular degeneration to accurately check their vision in less than 90 seconds, according to its developers. myVisionTrack is designed specifically to treat patients suffering from diabetic retinopathy and macular degeneration, which together are the cause of much of the blindness in the world.
“Many patients do not have timely eye exams and end up suffering preventable vision loss,” explained Dr. Yu-Guang He, an associate professor of ophthalmology at UT Southwestern in a press release. “Careful self-monitoring is critical because treatment for age-related macular degeneration and diabetic retinopathy is most effective when given at precise stages in the disease’s progression.”
Antioxidant May Stall Inherited Blindness (CME/CE)
(MedPage Today) — The antioxidant idebenone appeared to slow vision loss in patients with Leber’s hereditary optic neuropathy (LHON), particularly when sight was worse in one eye than the other, according to an international study.
Finding It Harder To See The Wood For The Trees: Changes In Attention And Visual Perception Are Correlated With Aging
When looking at a picture of many trees, young people will tend to say: “This is a forest”. However, the older we get, the more likely we are to notice a single tree before seeing the forest. This suggests that the speed at which the brain processes th…
For Patients With Inherited Blindness, Drug Shown To Improve Sight
A clinical trial led by Newcastle University shows that the drug, idebenone (Catena®), improved the vision and perception of colour in patients with Leber’s Hereditary Optic Neuropathy (LHON). The inherited condition means patients, who can see normal…
Retinal Cells Thoughts To Be The Same Are Not, Biologist Says
The old adage “Looks can be deceiving” certainly rings true when it comes to people. But it is also accurate when describing special light-sensing cells in the eye, according to a Johns Hopkins University biologist…